Covenant Asset Management, LLC Gilead Sciences, Inc. Transaction History

Covenant Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 26, 2019	SELL	$62.53 - $70.05 $207,912 - $232,916	-3,325 Closed	0 $0
Q3 2018 Oct 09, 2018	SELL	$71.28 - $78.92 $28,512 - $31,568	-400 Reduced 10.74%	3,325 $257,000
Q2 2018 Jul 12, 2018	BUY	$64.88 - $75.68 $37,306 - $43,516	575 Added 18.25%	3,725 $264,000
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $14,568 - $17,760	-200 Reduced 5.97%	3,150 $237,000
Q4 2017 Jan 12, 2018	SELL	$71.15 - $83.52 $14,230 - $16,704	-200 Reduced 5.63%	3,350 $240,000
Q3 2017 Oct 19, 2017	BUY	$72.11 - $85.47 $255,990 - $303,418	3,550	3,550 $288,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Covenant Asset Management, LLC with notifications on news.